PRADAXA 30 mg, granulés enrobés — 60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930223925
  • CIP7 3022392
  • CIS 61714127
  • Registration number EU/1/08/442

What the source publishes

Holder
BOEHRINGER INGELHEIM INTERNATIONAL
Active ingredients
DABIGATRAN ÉTEXILATE, MÉSILATE DE DABIGATRAN ÉTEXILATE
Form
granulés enrobé
Package
60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium
Routes
orale
Administrative status
Présentation active
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2021-01-11
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930223925
{
  "cis": "61714127",
  "cip7": "3022392",
  "form": "granulés enrobé",
  "name": "PRADAXA 30 mg, granulés enrobés — 60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium",
  "cip13": "3400930223925",
  "holder": "BOEHRINGER INGELHEIM INTERNATIONAL",
  "routes": [
    "orale"
  ],
  "holders": [
    "BOEHRINGER INGELHEIM INTERNATIONAL"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2021-01-11",
  "compositions": [
    {
      "name": "DABIGATRAN ÉTEXILATE",
      "nature": "FT",
      "strength": "30 mg",
      "linkageNumber": "1",
      "substanceCode": "82447",
      "dosageReference": "un sachet",
      "pharmaceuticalElement": "granulés"
    },
    {
      "name": "MÉSILATE DE DABIGATRAN ÉTEXILATE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "83321",
      "dosageReference": null,
      "pharmaceuticalElement": "granulés"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "PRADAXA 30 mg, granulés enrobés",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2026-10-16",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DABIGATRAN ÉTEXILATE",
    "MÉSILATE DE DABIGATRAN ÉTEXILATE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation archivée",
  "europeanAuthorisationNumber": "EU/1/08/442",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930223925"